Skip to main content
Advertisement
Advertisement
BLCO
BLCO logo
Bausch + Lomb Corporation
19.38
USD
Sponsored
-1.31
-6.33%
Nov 20, 15:59 UTC -5
Closed
exchange

After-Market

19.39

+0.01
+0.03%

Bausch + Lomb Corporation (BLCO) Earnings

BLCO Earnings Reports

Positive Surprise Ratio

BLCO beat 14 of 18 last estimates.

78%

Next Report

Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/
--
Implied change from Q3 26 (Revenue/ EPS)
--
/
--
Implied change from Q-- -- (Revenue/ EPS)
--
/
--

Bausch + Lomb Corporation earnings per share and revenue

On Oct 28, 2026, BLCO reported earnings of 0.34 USD per share (EPS) for Q3 26, beating the estimate of 0.22 USD, resulting in a 53.43% surprise. Revenue reached 1.38 billion, compared to an expected 1.40 billion, with a -1.84% difference. The market reacted with a +15.78% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Freenome, Inc. Common stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
$0.41
Actual
$0.57
Surprise
+38.69%
logo
SBC Medical Group Holdings Incorporated Common Stock
Report Date
Nov 13, 2026 For Q3 26
Estimate
$0.11
Actual
$0.15
Surprise
+32.63%
logo
Auna S.A.
Report Date
Nov 17, 2026 For Q3 26
Estimate
$0.85
Actual
$0.27
Surprise
-68.34%
logo
Park Dental Partners, Inc. Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
$0.30
Actual
$0.56
Surprise
+86.27%
logo
LifeMD, Inc. Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.14
Actual
-$0.11
Surprise
+23.77%
logo
Ainos, Inc. Common Stock
Report Date
Nov 16, 2026 For Q3 26
Estimate
-
Actual
-$0.25
Surprise
-
logo
Lifeward Ltd. Ordinary Shares
Report Date
Nov 13, 2026 For Q3 26
Estimate
-$0.83
Actual
-$1.32
Surprise
-57.82%
logo
SeaStar Medical Holding Corporation Common Stock
Report Date
Nov 11, 2026 For Q3 26
Estimate
-$0.93
Actual
-$1.03
Surprise
-10.24%
logo
IceCure Medical Ltd. Ordinary Shares
Report Date
Nov 18, 2026 For Q3 26
Estimate
-$1.18
Actual
-$0.40
Surprise
+66.19%
logo
20/20 Biolabs, Inc. Common Stock
Report Date
Nov 16, 2026 For Q3 26
Estimate
-$0.14
Actual
-$0.12
Surprise
+15.97%
FAQ
For Q3 2026, Bausch + Lomb Corporation reported EPS of $0.34, beating estimates by 53.43%, and revenue of $1.38B, -1.84% below expectations.
The stock price moved up 15.78%, changed from $17.62 before the earnings release to $20.40 the day after.
The next earning report is scheduled for --.
Based on -- analysts, Bausch + Lomb Corporation is expected to report EPS of -- and revenue of -- for Q-- --.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement